Research Keyword: chronic pulmonary aspergillosis

Diagnostic performance of Aspergillus-specific immunoglobulin G immunochromatographic and enzyme-linked immunosorbent assay testing in chronic pulmonary aspergillosis: comparative analysis across subtypes and influencing factors

mycolabadmin

This study compared two blood tests for diagnosing chronic pulmonary aspergillosis (CPA), a chronic fungal lung infection caused by Aspergillus. The rapid immunochromatographic test (ICT) performed better overall than the traditional ELISA laboratory test, making it more useful as a quick diagnostic tool, especially in areas without advanced laboratory facilities. However, both tests were less accurate in patients who had recently taken antifungal or steroid medications.

Read More »

ABPA in post-tuberculosis lung disease: A diagnostic pitfall or genuine entity?

mycolabadmin

This article addresses confusion between two Aspergillus lung infections that commonly occur after tuberculosis: ABPA and CPA. While they have overlapping symptoms and test results, they require different treatments—ABPA responds to short-term steroids while CPA needs prolonged antifungal drugs. Importantly, giving steroids for misdiagnosed CPA can be harmful, so doctors should be cautious about diagnosing ABPA in tuberculosis survivors and consider CPA instead.

Read More »

Diagnostic performance of Aspergillus-specific immunoglobulin G immunochromatographic and enzyme-linked immunosorbent assay testing in chronic pulmonary aspergillosis: comparative analysis across subtypes and influencing factors

mycolabadmin

Chronic pulmonary aspergillosis is a serious fungal lung infection that often develops after tuberculosis. This study compared two blood tests for diagnosing this disease: a quick point-of-care test and a traditional lab test. The quick test performed better overall and could be used in areas without advanced laboratory equipment, though previous antifungal or steroid medications can reduce its effectiveness.

Read More »

Pulmonary Aspergilloma in a Non-adherent Systemic Lupus Erythematosus Patient Receiving Long-Term Immunosuppression: A Report of a Rare Case

mycolabadmin

A patient with systemic lupus erythematosus (SLE), a chronic autoimmune disease treated with long-term immune-suppressing medications, developed a serious fungal lung infection called pulmonary aspergilloma. Despite the complexity of managing multiple conditions and extensive bilateral lung involvement, the patient was successfully treated with prolonged voriconazole antifungal therapy rather than surgery, emphasizing the importance of early recognition and tailored treatment in immunocompromised patients.

Read More »

Diagnostic performance of Aspergillus-specific immunoglobulin G immunochromatographic and enzyme-linked immunosorbent assay testing in chronic pulmonary aspergillosis: comparative analysis across subtypes and influencing factors

mycolabadmin

Chronic pulmonary aspergillosis (CPA) is a serious fungal lung infection that primarily affects people with existing lung conditions. This study compared two methods to detect the disease: a fast, portable test (ICT) and a traditional laboratory test (ELISA). The faster ICT test was more accurate overall and can provide results quickly in areas without advanced laboratory facilities. However, patients already taking antifungal medications had lower test accuracy with both methods.

Read More »
Scroll to Top